Alnylam Pharmaceuticals, Inc.

Amvuttra

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Amvuttra – J0225

Manufacturer:

Alnylam Pharmaceuticals, Inc.

Name:

Amvuttra

HCPCS Code Descriptor:

Injection, vutrisiran, 1 mg

Category:

J Code

HCPCS:

J0225

NDC(s):

71336-1003-01

Primary Type:

Genetic Disorder

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

Amvuttra is a Genetic Disorder drug manufactured by Alnylam Pharmaceuticals, Inc. and administered via the Subcutaneous route of administration. The J Code: J0225 is aligned to the drug Amvuttra.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/23

HCPCS Effective Date:

1/1/23

HCPCS Short Description:

Inj, vutrisiran, 1 mg

Billing and Coding Guide:

https://www.alnylamassist.com/sites/default/files/pdfdownloads/AMVUTTRA-vutrisiran-Billing-Coding-Physician.pdf

Patient Assistance:

https://www.alnylamassist.com/